Stem cell based gene therapy for Recombinase deficient-SCID
Recombinase-activating gene (RAG) deficient SCID patients lack B and T lymphocytes
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Recombinase-activating gene (RAG) deficient SCID patients lack B and T lymphocytes
Despite the significant recent advances in the therapeutics for cancer, it still
cell-based therapy to treat Parkinson’s disease (PD), we have developed a Good Manufacturing Practice (GMP)-compatible process for generating authentic midbrain (A9/A10) dopaminergic neurons using defined media
biological analytes. In this report, we have demonstrated the feasibility of a novel cell-based biosensor that utilizes a microcantilever to convert a cellular response to a measurable mechanical response ... effects on…
Cells and tissues for transplantation constitute a specific class of health products
Chronic kidney diseases affect thousands of people worldwide and the final consequence
The goal of our work is to develop insight and understanding of
The current interest and scientific progress in progenitor and stem cell biology
Th e DC-based therapeutic vaccine has been a theoretically attractive approach
Background & Aims: Dendritic cell (DC)-based immunotherapy is a promising viable tool
with each passing month that does not result in a pregnancy. In recent years, cell-based therapy has gained popularity to treat various conditions. The classical dogma regarding female fecundity ... endogenous…
antibodies (3.3, 6.3, 7A4, or 15-2b) to optimize an anti-PEG cell-based sandwich ELISA. Then, we quantified free PEG (mPEG2K-NH2 and mPEG5K-NH2) or PEG-conjugated ... with 15- 2b are more suitable for quantifying…
While stem cell-based therapies have demonstrated immunomodulatory, anti-inflammatory and tissue-reparative functions in acute disease settings, they are less effective when administered to chronically damaged organs…
cell biology in general and in high-throughput cell-based screening approaches in particular - e.g. for in vitrobased toxicity assessment - various methodologies or protocols are reported in the literature ... case that…
Recent decades have witnessed many advances in development of Cell-Based Biosensors (CBBs) for addressing clinical, environmental and toxicological problems. While some could be useful means for diagnosis, prognosis…
Recent decades have witnessed many advances in development of cell-based biosensors (CBBs) for addressing clinical, environmental and toxicological problems. While some could be useful means for diagnosis, prognosis…
saving time and resources, if used appropriately. At the beginning of the planning of cell-based product development, it is important to know what the regulatory framework for the specific
Conclusion: We have shown for the first time in a translational animal model that cell-based therapy is effective in protecting the preterm brain against the cerebral and peripheral inflammatory ... hypoxia-ischemia…
this study, we aim to overcome compromised development of hard tissue using 3D cell-based tissue engineering strategies. Specifically, we quantified the effect of a biomimetic template and cell seeding ... cell…
model with T, CTL and Dendritic cells and finally a model with a dendritic cell-based vaccine. From the model analysis, a cell-based vaccine can help effectively control
stem cell-based protocols in transplantation has rapidly achieved many long-sought goals, including the induction of donor-specific tolerance and as an effective immunomodulatory therapy against acute cellular rejection…
Stem cell-based regenerative medicine has revolutionized the way we approach tissue repair and disease treatment. With their unique ability to self-renew and differentiate into diverse cell types, stem
challenges and ethical considerations associated with stem cell research and clinical translation. Stem cell-based therapies hold great promise for regenerative medicine and have the potential to revolutionize healthcare
cell derived-neurons can successfully engraft, differentiate, and integrate into the neural tissues. Stem cell-based therapies associate with important challenges including poor cell survival, limited differentiation…
clinical-grade isolating methods, MPCs could represent a new tool for the implementation of cell-based medicinal products (CBMPs) applicable for skeletal tissue regeneration, as these cells could also support
For authors and organisers
Find the right journal for your paper and submit your manuscript.